Pooling orders for life-saving medicines can help drive down their cost and ensure a steady supply for low- and middle-income countries, though there are trade-offs, according to a new study led by a University of Massachusetts health economist and published in the May issue of the Journal of Health Economics.
This article was originally published on MedicalXpress.com